Skip to main content
Clinical Trials/NCT02248129
NCT02248129
Completed
Not Applicable

Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated in General Practice With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide, the Level of Blood Pressure Control and the Modalities of Arterial Hypertension Management

Boehringer Ingelheim0 sites4,255 target enrollmentApril 2006

Overview

Phase
Not Applicable
Intervention
Telmisartan and hydrochlorothiazide
Conditions
Hypertension
Sponsor
Boehringer Ingelheim
Enrollment
4255
Primary Endpoint
Percentage of patients with low blood pressure
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Study to compare the level of blood pressure control in hypertensive, hypertensive diabetics and hypertensive with renal insufficiency (observed data) in the study population, with the objectives of the High Authority for Health recommendations (benchmark)

Registry
clinicaltrials.gov
Start Date
April 2006
End Date
December 2006
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Hypertensive patients already treated for at least 1 month with Telmisartan plus hydrochlorothiazide, consulting the physician consecutively for whatever reason

Exclusion Criteria

  • Not provided

Arms & Interventions

Hypertensive patients

Intervention: Telmisartan and hydrochlorothiazide

Outcomes

Primary Outcomes

Percentage of patients with low blood pressure

Time Frame: up to 4 weeks

lower than 140/90 mmHg in the general population of hypertensive patients, hypertensive diabetics and hypertensive with renal insufficiency

Secondary Outcomes

  • Number of patients with adverse events(up to 4 weeks)

Similar Trials